SCHEMBL2829197

SCHEMBL2829197

NC(=C1C(=O)Nc2ccccc21)c1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.49
▸ LRRK2 Q5S007 3/20 0.49
▸ AGTR1 P30556 2/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ KDR P35968 1/20 0.49
▸ PIM1 P11309 2/20 0.44
▸ IDO1 P14902 2/20 0.43
▸ TDO2 P48775 1/20 0.43
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ PDGFRA P16234 1/20 0.43
▸ FER P16591 1/20 0.43
▸ LTK P29376 1/20 0.43
▸ CDK8 P49336 1/20 0.43
▸ ACVR1 Q04771 1/20 0.43
▸ DYRK1B Q9Y463 1/20 0.43
▸ BACE1 P56817 1/20 0.43
▸ MAPT P10636 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2829194 1.00 TDP1 (0.49) TDP1LRRK2AGTR1KMT2AKDR
SCHEMBL13207359 1.00 TDP1 (0.49) TDP1LRRK2AGTR1KMT2AKDR
SCHEMBL2829329 0.87 TDP1 (0.50) TDP1LRRK2KMT2APIM1IDO1
SCHEMBL2829327 0.87 TDP1 (0.50) TDP1LRRK2KMT2APIM1IDO1
SCHEMBL2826123 0.86 PLK4 (0.50) TDP1LRRK2KMT2APIM1IDO1
SCHEMBL2826121 0.86 PLK4 (0.50) TDP1LRRK2KMT2APIM1IDO1
SCHEMBL13207305 0.86 PLK4 (0.50) TDP1LRRK2KMT2APIM1IDO1
SCHEMBL4999345 0.85 TDP1 (0.52) TDP1LRRK2AGTR1KMT2APIM1
SCHEMBL13207307 0.85 TDP1 (0.49) TDP1LRRK2AGTR1PIM1IDO1
SCHEMBL2829139 0.85 TDP1 (0.49) TDP1LRRK2AGTR1PIM1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781475-B2 Oxindoles as kinase inhibitors MERCK PATENT GMBH (DE) 2010-08-24 — — US claimed
US-20100197757-A1 OXINDOLES AS KINASE INHIBITORS BURGDORF LARS THORE 2010-08-05 — — US claimed
US-20090131506-A1 Oxindoles as Kinase Inhibitors MERCK PATENT GMBH (DE) 2009-05-21 — — US claimed
EP-1891008-A1 OXINDOLES AS KINASE INHIBITORS Merck Patent GmbH (DE) 2008-02-27 — — EP claimed
WO-2006131186-A1 OXINDOLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2006-12-14 — — WO claimed
US-7781475-B2 Oxindoles as kinase inhibitors MERCK PATENT GMBH (DE) 2010-08-24 — — US disclosed
US-20100197757-A1 OXINDOLES AS KINASE INHIBITORS BURGDORF LARS THORE 2010-08-05 — — US disclosed
EP-1891008-B1 OXINDOLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2010-06-30 — — EP disclosed
US-20090131506-A1 Oxindoles as Kinase Inhibitors MERCK PATENT GMBH (DE) 2009-05-21 — — US disclosed
EP-1891008-A1 OXINDOLES AS KINASE INHIBITORS Merck Patent GmbH (DE) 2008-02-27 — — EP disclosed
WO-2006131186-A1 OXINDOLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2006-12-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197757-A1 OXINDOLES AS KINASE INHIBITORS MAP4K2, MAP3K20, MAP3K1 TDP1 2148/4885LRRK2 330/4885AGTR1 887/4885
US-20090131506-A1 Oxindoles as Kinase Inhibitors MAP4K2, MAP3K20, MAP3K1 TDP1 2148/4885LRRK2 330/4885AGTR1 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback